The convenient, virtually pain-free blood lancet device helps collect whole liquid blood samples. Credit: OsloMetX from Pixabay.

Tasso has obtained CE mark certification for its latest generation, virtually pain-free whole blood collection lancet device, Tasso+.

The device is intended for collecting whole liquid blood samples.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Meanwhile, the certification enables the company to market its patient-centric, high-volume blood collection solution in the European Union market, including 28 member states, as well as in Lichtenstein, Iceland and Norway.

Designed to obtain microliter capillary whole blood samples, the single-use blood-lancing device facilitates the collection of virtually painless blood samples with a user-friendly interface.

Furthermore, the device is suitable for use with compatible collection tubes to expedite decentralised clinical trials for pharmaceutical companies, specifically for pharmacokinetic and biomarker research endpoints.

It also helps physicians and healthcare systems determine the blood chemistry of their patients and expand access to care.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Tasso CEO and co-founder Ben Casavant said: “This designation is an important milestone for Tasso, allowing us to build upon the success of our CE-marked Tasso-M20 device and continue to expand our commercial footprint and reduce healthcare access barriers in Europe, where demand increasingly grows for patient-centric solutions.

“The Tasso+ CE mark enables us to support the pharmaceutical industry, academic and government institutions on research and clinical initiatives, as well as accelerate access to remote testing and care for more patient populations. We are excited to expand our customer base in Europe.”

In August last year, the company received Class II 510(k) clearance from the US Food and Drug Administration for this lancet device.

Medical Device Network Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Medical Device Network Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving medical devices advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now